Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 6, 2014, Pages 1520-1531

  Li, Heng Hong ^a   Tyburski, John B ^a   Wang, Yi Wen ^a   Strawn, Steve ^a   Moon, Bo Hyun ^a   Kallakury, Bhaskar V S ^b   Gonzalez, Frank J ^c   Fornace, Albert J ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Fibrogenesis; Metabolic Pathways; Metabolomics; Ppara Null Mice; Transcriptomics

Indexed keywords

ALCOHOL; BILE ACID; FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRICARBOXYLIC ACID;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CONTROLLED STUDY; ELECTRON TRANSPORT; FATTY ACID METABOLISM; GENE EXPRESSION; HISTOPATHOLOGY; LIVER PROTECTION; MALE; METABOLOMICS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DNA MICROARRAY; DRUG EFFECTS; FIBROSIS; LIVER; LIVER MITOCHONDRION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BILE ACIDS AND SALTS; ETHANOL; FATTY ACIDS; FIBROSIS; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; METABOLOMICS; MICE; MITOCHONDRIA, LIVER; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR ALPHA;

EID: 84901950316     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12424     Document Type: Article

References (40)

1. Allen K, Jaeschke H, Copple BL (2011) Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 178:175-186.
2. Aranha MM, Cortez-Pinto H, Costa A, da Silva IB, Camilo ME, de Moura MC, Rodrigues CM (2008) Bile acid levels are increased in the liver of patients with steatohepatitis. Eur J Gastroenterol Hepatol 20:519-525.
3. Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S (2005a) Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res 29:121S-131S.
4. Breitkopf K, Sawitza I, Westhoff JH, Wickert L, Dooley S, Gressner AM (2005b) Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut 54:673-681.
5. Chen A (2002) Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Biochem J 368:683-693.
6. Crabb DW, Liangpunsakul S (2006) Alcohol and lipid metabolism. J Gastroenterol Hepatol 21(Suppl 3):S56-S60.
7. Desvergne B, Michalik L, Wahli W (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 18:1321-1332.
8. Diehl AM (2002) Liver disease in alcohol abusers: clinical perspective. Alcohol 27:7-11.
9. Fang JW, Bird GL, Nakamura T, Davis GL, Lau JY (1994) Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet 343:820-823.
10. Fischer M, You M, Matsumoto M, Crabb DW (2003) Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 278:27997-28004.
11. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW (2001) The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem 276:68-75.
12. Holsti P (1956) Experimental cirrhosis of the liver in rabbits induced by gastric instillation of desiccated whole bile. Acta Pathol Microbiol Scand Suppl 39:1-66.
13. Ji C, Chan C, Kaplowitz N (2006) Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 45:717-724.
14. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103:1489-1498.
15. Li F, Patterson AD, Krausz KW, Tanaka N, Gonzalez FJ (2012) Metabolomics reveals an essential role for peroxisome proliferator-activated receptor alpha in bile acid homeostasis. J Lipid Res 53:1625-1635.
16. Lumeng L, Crabb DW (2001) Alcoholic liver disease. Curr Opin Gastroenterol 17:211-220.
17. Ma X, Baraona E, Lieber CS (1993) Alcohol consumption enhances fatty acid omega-oxidation, with a greater increase in male than in female rats. Hepatology 18:1247-1253.
18. MacSween RN, Burt AD (1986) Histologic spectrum of alcoholic liver disease. Semin Liver Dis 6:221-232.
19. Mak TD, Laiakis EC, Goudarzi M, Fornace AJJ (2014) MetaboLyzer: a novel statistical workflow for analyzing postprocessed LC-MS metabolomics data. Anal Chem 86:506-513.
20. Manna SK, Patterson AD, Yang Q, Krausz KW, Li H, Idle JR, Fornace AJJ, Gonzalez FJ (2010) Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res 9:4176-4188.
21. Masuhara M, Yasunaga M, Tanigawa K, Tamura F, Yamashita S, Sakaida I, Okita K (1996) Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology 24:323-329.
22. van der Meer DL, Degenhardt T, Vaisanen S, de Groot PJ, Heinaniemi M, de Vries SC, Muller M, Carlberg C, Kersten S (2010) Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucleic Acids Res 38:2839-2850.
23. Mello T, Polvani S, Galli A (2009) Peroxisome proliferator-activated receptor and retinoic × receptor in alcoholic liver disease. PPAR Res 2009:748174.
24. Menon KV, Gores GJ, Shah VH (2001) Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc 76:1021-1029.
25. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T (2004) Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40:972-980.
26. Nan YM, Kong LB, Ren WG, Wang RQ, Du JH, Li WC, Zhao SX, Zhang YG, Wu WJ, Di HL, Li Y, Yu J (2013) Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice. Lipids Health Dis 12:11.
27. Palmer CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF (1998) Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 53:14-22.
28. Pignon JP, Bailey NC, Baraona E, Lieber CS (1987) Fatty acid-binding protein: a major contributor to the ethanol-induced increase in liver cytosolic proteins in the rat. Hepatology 7:865-871.
29. Podevin P, Rosmorduc O, Conti F, Calmus Y, Meier PJ, Poupon R (1999) Bile acids modulate the interferon signalling pathway. Hepatology 29:1840-1847.
30. Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM (2001) Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 21:1840-1845.
31. Rabinowitz JL, Staeffen J, Hall CL, Brand JG (1991) A probable defect in the beta-oxidation of lipids in rats fed alcohol for 6 months. Alcohol 8:241-246.
32. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, Haussinger D (2005) Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 129:2009-2031.
33. Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K (1990) Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12:1216-1221.
34. Shi X, Yao D, Gosnell BA, Chen C (2012) Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity. J Lipid Res 53:2318-2330.
35. Sugden MC, Caton PW, Holness MJ (2010) PPAR control: it's SIRTainly as easy as PGC. J Endocrinol 204:93-104.
36. Tatekawa Y, Nakada A, Nakamura T (2013) Intrahepatic biliary ablation with pure ethanol: an experimental model of biliary atresia. Surg Today 43:661-669.
37. Tung BY, Carithers RLJ (1999) Cholestasis and alcoholic liver disease. Clin Liver Dis 3:585-601.
38. Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW (1995) Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 56:307-317.
39. Wan YY, Cai Y, Li J, Yuan Q, French B, Gonzalez FJ, French S (2001) Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice. Hepatol Res 19:117-130.
40. You M, Fischer M, Deeg MA, Crabb DW (2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277:29342-29347.